This inventor holds 1 USPTO granted patent. Top assignee: S O 'Pharmachim'. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Keranka N Savova: Innovator in Antihypoxic Drug Development
Introduction
Keranka N Savova is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypoxic drugs. His innovative approach combines various compounds to enhance therapeutic effects, showcasing his expertise in medical science.
Latest Patents
Savova holds a patent for an antihypoxic drug and method of its application. This drug, which contains piracetam and orotic acid or their pharmaceutically tolerable salts, is designed to provide verebroprotective and hepatoprotective action. The formulation is administered for the treatment of both acute and chronic diseases, as well as exogenic intoxications. The drug can be taken in daily doses ranging from 0.150 to 50 g, depending on the severity of the condition. Clinical data supports the synergistic effect of the combination, demonstrating its efficacy in antihypoxic action. The drug can be administered orally or parenterally, with various forms available for different treatment needs.
Career Highlights
Savova is associated with S O Pharmachim, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that address critical health issues. His dedication to research and development has positioned him as a key player in the industry.
Collaborations
Savova collaborates with talented professionals in his field, including Ani I Genova and Milka P Nikolova. These partnerships enhance the research and development process, leading to more effective pharmaceutical solutions.
Conclusion
Keranka N Savova's contributions to the field of antihypoxic drugs highlight his innovative spirit and commitment to improving health outcomes. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile